Russia’s participation in the largest international register CLARIFY, monitoring coronary heart disease patients
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
References
1. Borer JS, Fox K, Jaillon P, et al. Anti-anginal and anti-ischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blinded, multicentered, placebo-controlled trial. Circulation 2003; 107: 817-23.
2. Tardif JC, Ford I, Tendera M, Bourassa MG. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005; 26: 252936.
3. Ruzyllo W, Ford I, Tendera M, et al. Antianginal and anti-ischemic effects of ivabradine compared to amlodipine in patients with stable effort angina: a 3-month randomized, double-blind, multicentre, noninferiority trial. Drugs 2007; 67: 393-405.
4. Tardif JC, Ponikowski P, Kahan T. for the ASSOCIATE. Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-bloker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 2009; 30: 540-8.
5. Fox K, Ford L, Steg PG, et al. on behalf of the BEUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008; 37: 807-16.
6. Fox1 K, Ford I, Steg PG, et al. on behalf of the BEAUTIFUL investigators. Eur Heart J FAST Track https://doi.org/10.1093/eurheartj/ ehp358. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
7. Karpov Yu.A., Deev A.D. ot imeni uchastnikov programmy AL''TERNATIVA. Programma AL''TERNATIVA - issledovanie antianginal'noi effektivnosti i perenosimosti koraksana (ivabradina) i otsenka kachestva zhizni patsientov so stabil'noi stenokardiei: rezul'taty epidemiologicheskogo etapa. Kardiovask ter profil 2008; 5: 30-5.
8. VNOK. Diagnostika i lechenie stabil'noi stenokardii. Rossiiskie rekomendatsii (vtoroi peresmotr). Kardiovask ter profil 2008; prilozhenie 4.
Review
For citations:
Onoprienko A.A. Russia’s participation in the largest international register CLARIFY, monitoring coronary heart disease patients. Cardiovascular Therapy and Prevention. 2009;8(7):130-132. (In Russ.)
Views:
368
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
